A Milestone Moment: FDA Approves Addyi® for Hypoactive Sexual Desire Disorder in Postmenopausal Women
December 17, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
tremfya
Synonyms :
guselkumab
Class :
Anti-psoriatic, monoclonal antibody
Brand Name :
tremfya
Synonyms :
guselkumab
Class :
Anti-psoriatic, monoclonal antibody
Dosage Forms & Strengths
Injectable solution
Single-dose prefilled syringe
100mg/ml
Single dose, one-press patient-controlled injector
100mg/ml
100mg subcutaneous at week 0, week four and every eight weeks
100mg subcutaneous at week 0, week four and every eight weeks
may decrease the therapeutic effect of immunosuppressants
may increase the immunosuppressive effect
may decrease the therapeutic effect of immunosuppressants
may increase the immunosuppressive effect
may decrease the therapeutic effect of immunosuppressants
measles, mumps, rubella, and varicella vaccine, live (Rx)
may decrease the therapeutic effect of immunosuppressants
measles mumps and rubella vaccine, live
may decrease the therapeutic effect of immunosuppressants
may decrease the therapeutic effect of immunosuppressants
vaccinia immune globulin intravenous (Rx)
may decrease the therapeutic effect of immunosuppressants
may decrease the therapeutic effect of immunosuppressants
may increase the immunosuppressive effect
may increase the immunosuppressive effect
may increase the toxic effect of immunosuppressants
may increase the immunosuppressive effect
may increase the toxic effect
may increase the immunosuppressive effect of immunosuppressants
may increase the immunosuppressive effect of immunosuppressants
may increase the toxic effect of immunosuppressants
It may enhance the immunosuppressive effects when combined with idecabtagene vicleucel
may decrease the therapeutic effect of immunosuppressants
may decrease the therapeutic effect
may increase the immunosuppressive effect of immunosuppressant
It may diminish the effects when combined with rozanolixizumab by receptor binding competition
It may enhance the adverse effects when combined with sotrovimab
Frequency defined:
>10%
Upper respiratory tract infections
Infections
1-10%
Injection site reaction
Herpes simplex infections
Elevated liver enzyme
Gastroenteritis
Headache
Arthralgia
Diarrhea
Tinea infections
Post-marketing reports
Rash
Hypersensitivity reactions
Pregnancy consideration:
US FDA Pregnancy category: B
Lactation: Excretion of the drug in human breast milk is unknown
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient information leaflet
Generic Name: guselkumab
Pronounced: (gue sel KOO mab)
Why do we use guselkumab?
It is used to treat plaque psoriasis and psoriatic arthritis in adults.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
